Abstract
A serological assay for the quantitative determination of the novel tumour-associated epitope CA242 was developed and used for determination of sensitivity and specificity of CA242 in gastrointestinal cancer. The CA242 assay showed a better tumour specificity than CA50 (and CA 19-9). This was most noticeable in benign hepatobiliary disease. The sensitivity at 90% specificity cut-off level was approximately three times higher for CA242 compared to CA50 in colo-rectal cancer Dukes A, B and C, while in pancreatic cancer the sensitivity of CA242 and CA50 was similar. CA242 was expressed independently of CEA, and the combination of CEA and CA242 gave in colo-rectal cancer considerably higher sensitivity than the use of only one of the markers. This was most pronounced in Dukes A and Dukes B patients. CA242 is a novel tumour marker of potential clinical use, particularly in colo-rectal cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nilsson, O., Johansson, C., Glimelius, B. et al. Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer 65, 215–221 (1992). https://doi.org/10.1038/bjc.1992.44
Issue Date:
DOI: https://doi.org/10.1038/bjc.1992.44
This article is cited by
-
Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection
Scientific Reports (2017)
-
Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer
Tumor Biology (2014)
-
Sensitivity Estimates of Blood-Based Tests for Colorectal Cancer Detection: Impact of Overrepresentation of Advanced Stage Disease
American Journal of Gastroenterology (2011)
-
A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland
Journal of Cancer Research and Clinical Oncology (2009)
-
Relationship between Matrix Metalloproteinase 2 and Lung Cancer Progression
Molecular Diagnosis & Therapy (2007)